Viking Therapeutics (NASDAQ:VKTX) Price Target Raised to $31.00
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price raised by BTIG Research from $20.00 to $31.00 in a research report report published on Tuesday, The Fly reports. BTIG Research currently has a buy rating on the biotechnology company’s stock. Several other analysts have also recently commented on the stock. StockNews.com initiated coverage on […]